Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
Myelodysplastic syndromes (MDS) constitute a very heterogeneous group of diseases with a high prevalence in elderly patients and a propensity for progression to acute myeloid leukemia. The complexity of these hematopoietic malignancies is revealed by the multiple recurrent somatic mutations involved...
Main Authors: | Yannick Simoni, Nicolas Chapuis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/7/1659 |
Similar Items
-
Clonal hematopoiesis of indeterminate potential and heart failure
by: E. A. Lyasnikova, et al.
Published: (2024-12-01) -
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
by: Kelly S. Chien, et al.
Published: (2024-03-01) -
Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort
by: Rachel Jaber Chehayeb, et al.
Published: (2024-11-01) -
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy
by: Tiziano Barbui
Published: (2022-07-01) -
Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
by: Anna Maria Cacic, et al.
Published: (2023-12-01)